SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by the World Health Organization (WHO). Early clinical symptomatology focused mainly on respiratory illnesses. However, a variety of n...

Full description

Bibliographic Details
Main Authors: Pinar Mesci, Janaina S. de Souza, Laura Martin-Sancho, Angela Macia, Aurian Saleh, Xin Yin, Cedric Snethlage, Jason W. Adams, Simoni H. Avansini, Roberto H. Herai, Angels Almenar-Queralt, Yuan Pu, Ryan A. Szeto, Gabriela Goldberg, Patrick T. Bruck, Fabio Papes, Sumit K. Chanda, Alysson R. Muotri
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-11-01
Series:PLoS Biology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632769/?tool=EBI
_version_ 1797985651347423232
author Pinar Mesci
Janaina S. de Souza
Laura Martin-Sancho
Angela Macia
Aurian Saleh
Xin Yin
Cedric Snethlage
Jason W. Adams
Simoni H. Avansini
Roberto H. Herai
Angels Almenar-Queralt
Yuan Pu
Ryan A. Szeto
Gabriela Goldberg
Patrick T. Bruck
Fabio Papes
Sumit K. Chanda
Alysson R. Muotri
author_facet Pinar Mesci
Janaina S. de Souza
Laura Martin-Sancho
Angela Macia
Aurian Saleh
Xin Yin
Cedric Snethlage
Jason W. Adams
Simoni H. Avansini
Roberto H. Herai
Angels Almenar-Queralt
Yuan Pu
Ryan A. Szeto
Gabriela Goldberg
Patrick T. Bruck
Fabio Papes
Sumit K. Chanda
Alysson R. Muotri
author_sort Pinar Mesci
collection DOAJ
description The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by the World Health Organization (WHO). Early clinical symptomatology focused mainly on respiratory illnesses. However, a variety of neurological manifestations in both adults and newborns are now well-documented. To experimentally determine whether SARS-CoV-2 could replicate in and affect human brain cells, we infected iPSC-derived human brain organoids. Here, we show that SARS-CoV-2 can productively replicate and promote death of neural cells, including cortical neurons. This phenotype was accompanied by loss of excitatory synapses in neurons. Notably, we found that the U.S. Food and Drug Administration (FDA)-approved antiviral Sofosbuvir was able to inhibit SARS-CoV-2 replication and rescued these neuronal alterations in infected brain organoids. Given the urgent need for readily available antivirals, these results provide a cellular basis supporting repurposed antivirals as a strategic treatment to alleviate neurocytological defects that may underlie COVID-19- related neurological symptoms. This study shows that SARS-CoV-2 virus can infect human brain cortical organoids, inducing cell death and synapse loss; application of Sofosbuvir, an FDA-approved antiviral, rescues these neuronal alterations in infected brain organoids.
first_indexed 2024-04-11T07:21:26Z
format Article
id doaj.art-d270539d16b945478c694db07d712953
institution Directory Open Access Journal
issn 1544-9173
1545-7885
language English
last_indexed 2024-04-11T07:21:26Z
publishDate 2022-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj.art-d270539d16b945478c694db07d7129532022-12-22T04:37:36ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852022-11-012011SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with SofosbuvirPinar MesciJanaina S. de SouzaLaura Martin-SanchoAngela MaciaAurian SalehXin YinCedric SnethlageJason W. AdamsSimoni H. AvansiniRoberto H. HeraiAngels Almenar-QueraltYuan PuRyan A. SzetoGabriela GoldbergPatrick T. BruckFabio PapesSumit K. ChandaAlysson R. MuotriThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by the World Health Organization (WHO). Early clinical symptomatology focused mainly on respiratory illnesses. However, a variety of neurological manifestations in both adults and newborns are now well-documented. To experimentally determine whether SARS-CoV-2 could replicate in and affect human brain cells, we infected iPSC-derived human brain organoids. Here, we show that SARS-CoV-2 can productively replicate and promote death of neural cells, including cortical neurons. This phenotype was accompanied by loss of excitatory synapses in neurons. Notably, we found that the U.S. Food and Drug Administration (FDA)-approved antiviral Sofosbuvir was able to inhibit SARS-CoV-2 replication and rescued these neuronal alterations in infected brain organoids. Given the urgent need for readily available antivirals, these results provide a cellular basis supporting repurposed antivirals as a strategic treatment to alleviate neurocytological defects that may underlie COVID-19- related neurological symptoms. This study shows that SARS-CoV-2 virus can infect human brain cortical organoids, inducing cell death and synapse loss; application of Sofosbuvir, an FDA-approved antiviral, rescues these neuronal alterations in infected brain organoids.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632769/?tool=EBI
spellingShingle Pinar Mesci
Janaina S. de Souza
Laura Martin-Sancho
Angela Macia
Aurian Saleh
Xin Yin
Cedric Snethlage
Jason W. Adams
Simoni H. Avansini
Roberto H. Herai
Angels Almenar-Queralt
Yuan Pu
Ryan A. Szeto
Gabriela Goldberg
Patrick T. Bruck
Fabio Papes
Sumit K. Chanda
Alysson R. Muotri
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
PLoS Biology
title SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
title_full SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
title_fullStr SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
title_full_unstemmed SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
title_short SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
title_sort sars cov 2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with sofosbuvir
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632769/?tool=EBI
work_keys_str_mv AT pinarmesci sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT janainasdesouza sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT lauramartinsancho sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT angelamacia sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT auriansaleh sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT xinyin sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT cedricsnethlage sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT jasonwadams sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT simonihavansini sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT robertohherai sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT angelsalmenarqueralt sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT yuanpu sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT ryanaszeto sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT gabrielagoldberg sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT patricktbruck sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT fabiopapes sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT sumitkchanda sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir
AT alyssonrmuotri sarscov2infectshumanbrainorganoidscausingcelldeathandlossofsynapsesthatcanberescuedbytreatmentwithsofosbuvir